United States · FDA National Drug Code directory
Cardiolite
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11994-001_d515f49a-8eb4-42f3-a7ee-1634a4804ca5
- Product NDC
- 11994-001
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
- Labeler
- Lantheus Medical Imaging, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19901220
- Source listing expiry
- 20261231
Source-listed ingredients
- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 VIAL in 1 BOX (11994-001-20) / 5 mL in 1 VIAL · 11994-001-20
- 5 VIAL in 1 BOX (11994-001-55) / 5 mL in 1 VIAL · 11994-001-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →